Skip to content

Effectiveness of the Tecaretherapy in Patients With Lateral Elbow Tendinopathy

Effectiveness of High Frequency Currents (Tecarethérapie) in Patients With Lateral Elbow Tendonopathy

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03939247
Enrollment
17
Registered
2019-05-06
Start date
2019-04-25
Completion date
2021-07-01
Last updated
2021-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tendinopathy

Keywords

elbow, tendinopathy, physiotherapy, exercise, electrotherapy

Brief summary

This RCT aims at investigating the effectiveness of the Tecaretherapy in patients with lateral elbow tendinopathy. 60 patients will be randomized into one of the following 3 groups: * Conventional physiotherapy treatment (CPT) (massage, eccentric exercises, stretching); * CPT + Tecare (idem CPT group + tecaretherapy during the eccentric exercises) * CPT + Placebo Tecare (idem CPT + Tecare group but with an inactive Tecare device) The treatment will include 18 30-minute sessions

Detailed description

This RCT aims at investigating the effectiveness of the Tecaretherapy in patients with lateral elbow tendinopathy. 60 patients will be randomized into one of the following 3 groups: * Conventional physiotherapy treatment (CPT) (massage, eccentric exercises by means of an isokinetic dynamometer, stretching); * CPT + Tecare (idem CPT group + Tecaretherapy during the eccentric exercises) * CPT + Placebo Tecare (idem CPT + Tecare group but with an inactive Tecare device) The treatment will include 18 30-minute sessions. The Tecaretherapy consists in using a specific device providing high frequencies (between 300 kHz and 1 MHz) supposed to accelerate the tissues healing process. Outcome sessions will be organized at baseline, after the first 9 sessions, at the end of the treatment as well as 3 and 6 months after the initial treatment session.

Interventions

OTHERActive Tecaretherapy

The Tecaretherapy: consists of using a specific device providing high frequencies (between 300 kHz and 1 MHz) supposed to accelerate the tissues healing process

OTHERInactive Tecaretherapy

Inactive Tecaretherapy: the device will not provide any current.

OTHERCPT

Conventional physiotherapy treatment (massage, eccentric exercises, stretching)

Sponsors

University of Liege
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

The patients receiving the Placebo Tecare will be blinded by using an identical device as in the active group but which cannot provide any current

Intervention model description

Randomized controlled Trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Patient suffering from a chronic lateral elbow tendinopathy confirmed by echography

Exclusion criteria

Patients: * with contra-indications for a Tecaretherapy (Pace maker, insuline pump, pregnancy, infection, fever, cancer, thrombophlebitis) * reporting injections and/or shockwaves in the past (for the tendinopathy) * with an associated neurogenic dysfunction

Design outcomes

Primary

MeasureTime frameDescription
change in the Patient-Rated Tennis Elbow Evaluation scoreup to 6 monthsThis questionnaire, developped for patients with elbow tendinopathy, consists of one part dealing with pain and a second part dealing with function. Each of the 5 items in part 1 is scored using a NRS, ranging from 0 (no pain) to 10 (worst pain imaginable). Part 2 is subdivided into Specific Activities (6 items) and Usual Activities (4 items). The 10 items of part 2 use a scale of 0 (no difficulty) to 10 (unable to perform an activity) to rate function. The total score is the combined score that rates pain and disability of equal importance. The pain score total (out of 50 points) and the functional subscale (60 points for specific activities, plus 40 points for usual activities to give a function subscale out of 100 points /2 to provide the remaining 50%) provide a total score, ranging from 0 (no pain and no functional impairment) to 100 (worst pain imaginable with a very significant functional deficit).

Secondary

MeasureTime frameDescription
change in pain Intensityup to 6 months0-10 Numeric rating scale (0 = no pain, 10 = worst imaginable pain)
change in pain Pressure thresholdsup to 6 monthsMeasured by means of an algometer

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026